Global UNICEF is forecasting that between 16.8 billion and 20.9 billion COVID-19 vaccine doses will be produced in 2022. The Economist Intelligence Unit highlights the drivers of this incredible demand as the fact that booster shots will be needed to counter new variants; the increased number of countries requesting the Pfizer…

Global Pharmaceutical sales are expected to rise by 4.9 percent in 2022 according to the Economist Intelligence Unit (EIU) with the US continuing to lead the world in pharmaceutical sales numbers. This rise will be driven partly by COVID-19 vaccine sales and the development of other anti-COVID treatments and will also…

France The top ten pharma companies in France for 2021. Sanofi leads the pack with EUR 2.367 billion in turnover, followed by Servier (EUR 2.284 billion) and Janssen (EUR 1.175 billion).

Global The top COVID-19 Vaccines by revenue in 2021 and sales projections for 2022 based on Airfinity’s COVID-19 Vaccine Market Revenue Forecast 2022. Pfizer/BioNTech’s vaccine stands to make USD 42.69 billion in 2022, while Moderna’s product has projected sales of USD 25.71 billion. Projected USD 3.97 billion sales for Russia’s Sputnik…

Global Based on analysis from Crunchbase, read on for 2021’s largest VC investments into the biotech industry (which topped USD 65 billion last year) and 2021’s busiest biotech lead investors overall.   Made with Visme Infographic Maker   Made with Visme Infographic Maker

UK Oxford Nanopore hogged the UK biotech headlines in 2021, raising GBP 195 million in a single venture capital round – the year’s largest – and scoring a GBP 350 million listing on the London Stock Exchange, according to new data from the UK BioIndustry Association (BIA) and Clarivate. See below…

Japan An overview of the new medicines approved by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) between April and November 2021. See the 2020 data here and the full PMDA approval archive here. Made with Visme Infographic Maker

USA A comprehensive list of the US FDA’s Center for Drug Evaluation & Research (CDER)’s new drug therapy approvals for 2021. CDER approved 50 new drugs in 2021, down from 53 in 2020, either as new molecular entities (NMEs) under New Drug Applications (NDAs), or as new therapeutic biologics under Biologics…

MEA The top 10 fastest growing pharma companies in the Middle East and Africa (region) ranked by previous period growth between MAT Q2 2020 and MAT Q2 2021. The list is dominated by regional players including Julphar, Sedico/Acdima and Eva Pharma, but multinational firms are also represented by Gilead Sciences, Takeda,…

MEA The top 10 pharma companies in the Middle East and Africa (region) ranked by IQVIA’s 2021 sales figure data. The list is dominated by multinational players, with Hikma the only regional representative, and these 10 corporations account for 36 percent of the total market. French giant Sanofi sits in first…

Global Become a PharmaBoardroom Member for free to access this contentJoin the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Username Password Remember Me Forgot your password? Don't have a PharmaBoardroom account? Create one

Global Become a PharmaBoardroom Member for free to access this contentJoin the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In